We are live on
!
Find out more
MCM
Mason Capital Management Portfolio holdings
AUM
$607M
1-Year Est. Return
1.77%
This Fund
S&P 500
This Quarter
Est. Return
+4.72%
1 Year Est. Return
+1.77%
3 Year Est. Return
-18.46%
5 Year Est. Return
+39.95%
10 Year Est. Return
+284.4%
AUM
$9.55B
AUM Growth
+$1.15B
(+14%)
Cap. Flow
+$462M
Cap. Flow
% of AUM
4.84%
Top 10 Holdings %
Top 10 Hldgs %
48.95%
Holding
62
New
17
Increased
9
Reduced
8
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madison Square Garden
MSGS
|
+$327M |
| 2 |
Golar LNG
GLNG
|
+$295M |
| 3 |
THI
TIM HORTONS INC COM, CANADA
THI
|
+$277M |
| 4 |
Edgewell Personal Care
EPC
|
+$246M |
| 5 |
DuPont de Nemours
DD
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$361M |
| 2 |
AstraZeneca
AZN
|
+$249M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$212M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$211M |
| 5 |
AGN
Allergan Inc
AGN
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 26.52% |
| 2 | Miscellaneous | 17.7% |
| 3 | Technology | 14.21% |
| 4 | Communication Services | 11.83% |
| 5 | Materials | 8.77% |
Similar funds
CM
DIM
SCM
NPPM
SFCM
EA
BFC
VV
Mason Capital Management's Q3 2014 Portfolio in Review
As of Q3 2014, Mason Capital Management held 62 positions worth $9.55B, up 14% from $8.4B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Mason Capital Management deployed $462M of net new capital in Q3 2014, opening 17 new positions and adding to 9 existing holdings. Its largest new stake was Madison Square Garden: 7,261,836 shares worth $342M.
By sector, the portfolio is most concentrated in Energy at 27% of assets, up from 25% a quarter earlier, followed by Miscellaneous and Technology.
On the sell side, the largest reduction was Allergan Inc, an estimated $209M trimmed.
- Mason Capital Management's largest Q3 2014 buy was Madison Square Garden: 7,261,836 shares worth $342M.
- Mason Capital Management added most to Edgewell Personal Care in Q3 2014, an estimated $246M increase.
- Mason Capital Management's biggest Q3 2014 reduction was Allergan Inc, cutting an estimated $209M.
- Mason Capital Management fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $361M.
- Mason Capital Management's ten largest holdings make up 49% of its $9.55B portfolio in Q3 2014.
- Mason Capital Management opened 17 new positions and closed 14 in Q3 2014.
- Mason Capital Management's portfolio value rose 14% quarter-over-quarter to $9.55B.
Based on Mason Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.